{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T08:00:43Z","timestamp":1784707243893,"version":"3.55.0"},"reference-count":154,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100016714","name":"University of Sharjah","doi-asserted-by":"publisher","award":["24010901173"],"award-info":[{"award-number":["24010901173"]}],"id":[{"id":"10.13039\/100016714","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s00109-026-02704-7","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T05:43:29Z","timestamp":1784699009000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Kinase regulation of miRNA networks in cardiometabolic disease: emerging pathways to precision therapy"],"prefix":"10.1007","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6530-6068","authenticated-orcid":false,"given":"Firdos","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asima","family":"Karim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meganathan","family":"Kannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rizwan","family":"Qaisar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"issue":"25","key":"2704_CR1","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1016\/j.jacc.2023.11.007","volume":"82","author":"GA Mensah","year":"2023","unstructured":"Mensah GA et al (2023) Global burden of cardiovascular diseases and risks, 1990\u20132022. J Am Coll Cardiol 82(25):2350\u20132473","journal-title":"J Am Coll Cardiol"},{"key":"2704_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fcvm.2019.00016","volume":"6","author":"AW Aday","year":"2019","unstructured":"Aday AW, Ridker PM (2019) Targeting residual inflammatory risk: a shifting paradigm for atherosclerotic disease. Front Cardiovasc Med 6:16","journal-title":"Front Cardiovasc Med"},{"key":"2704_CR3","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1146\/annurev-biochem-060308-103103","volume":"79","author":"MR Fabian","year":"2010","unstructured":"Fabian MR, Sonenberg N, Filipowicz W (2010) Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 79:351\u2013379","journal-title":"Annu Rev Biochem"},{"issue":"8","key":"2704_CR4","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nrm3838","volume":"15","author":"M Ha","year":"2014","unstructured":"Ha M, Kim VN (2014) Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol 15(8):509\u2013524","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2704_CR5","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3389\/fcell.2020.00409","volume":"8","author":"PJ Dexheimer","year":"2020","unstructured":"Dexheimer PJ, Cochella L (2020) MicroRNAs: from mechanism to organism. Front Cell Dev Biol 8:409","journal-title":"Front Cell Dev Biol"},{"issue":"7449","key":"2704_CR6","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nature12080","volume":"497","author":"J Shen","year":"2013","unstructured":"Shen J et al (2013) EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2. Nature 497(7449):383\u2013387","journal-title":"Nature"},{"issue":"10","key":"2704_CR7","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/cr.2013.87","volume":"23","author":"N Nishida","year":"2013","unstructured":"Nishida N et al (2013) EGFR gets in the way of microRNA biogenesis. Cell Res 23(10):1157\u20131158","journal-title":"Cell Res"},{"issue":"3","key":"2704_CR8","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1161\/CIRCRESAHA.110.228676","volume":"109","author":"J Bauersachs","year":"2011","unstructured":"Bauersachs J, Thum T (2011) Biogenesis and regulation of cardiovascular microRNAs. Circ Res 109(3):334\u2013347","journal-title":"Circ Res"},{"issue":"9","key":"2704_CR9","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/s41569-022-00680-2","volume":"19","author":"D Santovito","year":"2022","unstructured":"Santovito D, Weber C (2022) Non-canonical features of microRNAs: paradigms emerging from cardiovascular disease. Nat Rev Cardiol 19(9):620\u2013638","journal-title":"Nat Rev Cardiol"},{"issue":"10","key":"2704_CR10","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s001090050063","volume":"74","author":"AJ Whitmarsh","year":"1996","unstructured":"Whitmarsh AJ, Davis RJ (1996) Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J Mol Med (Berl) 74(10):589\u2013607","journal-title":"J Mol Med (Berl)"},{"issue":"5","key":"2704_CR11","doi-asserted-by":"publisher","first-page":"E131","DOI":"10.1038\/ncb0502-e131","volume":"4","author":"E Shaulian","year":"2002","unstructured":"Shaulian E, Karin M (2002) AP-1 as a regulator of cell life and death. Nat Cell Biol 4(5):E131\u2013E136","journal-title":"Nat Cell Biol"},{"issue":"11","key":"2704_CR12","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s13238-011-1113-3","volume":"2","author":"Q Meng","year":"2011","unstructured":"Meng Q, Xia Y (2011) c-Jun, at the crossroad of the signaling network. Protein Cell 2(11):889\u2013898","journal-title":"Protein Cell"},{"key":"2704_CR13","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3389\/fgene.2014.00422","volume":"5","author":"HS Cheng","year":"2014","unstructured":"Cheng HS et al (2014) Noncoding RNAs regulate NF-kappaB signaling to modulate blood vessel inflammation. Front Genet 5:422","journal-title":"Front Genet"},{"issue":"18","key":"2704_CR14","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1042\/BCJ20253208","volume":"482","author":"F Ahmad","year":"2025","unstructured":"Ahmad F et al (2025) GSK-3alpha regulates miRNAs associated with transcriptional and metabolic processes in human cardiomyocytes under hypoxia. Biochem J 482(18):1321\u20131336","journal-title":"Biochem J"},{"issue":"6","key":"2704_CR15","doi-asserted-by":"publisher","first-page":"e20391","DOI":"10.1371\/journal.pone.0020391","volume":"6","author":"X Tang","year":"2011","unstructured":"Tang X et al (2011) Glycogen synthase kinase 3 beta (GSK3beta) phosphorylates the RNAase III enzyme Drosha at S300 and S302. PLoS One 6(6):e20391","journal-title":"PLoS One"},{"issue":"7","key":"2704_CR16","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/nrg3462","volume":"14","author":"G Meister","year":"2013","unstructured":"Meister G (2013) Argonaute proteins: functional insights and emerging roles. Nat Rev Genet 14(7):447\u2013459","journal-title":"Nat Rev Genet"},{"issue":"5589","key":"2704_CR17","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1126\/science.1073827","volume":"297","author":"G Hutvagner","year":"2002","unstructured":"Hutvagner G, Zamore PD (2002) A microRNA in a multiple-turnover RNAi enzyme complex. Science 297(5589):2056\u20132060","journal-title":"Science"},{"key":"2704_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241814290","author":"CE Fletcher","year":"2023","unstructured":"Fletcher CE, Taylor MA, Bevan CL (2023) PLK1 regulates microRNA biogenesis through Drosha phosphorylation. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms241814290","journal-title":"Int J Mol Sci"},{"issue":"5","key":"2704_CR19","first-page":"2809","volume":"45","author":"CE Fletcher","year":"2017","unstructured":"Fletcher CE et al (2017) A novel role for GSK3beta as a modulator of Drosha microprocessor activity and MicroRNA biogenesis. Nucleic Acids Res 45(5):2809\u20132828","journal-title":"Nucleic Acids Res"},{"issue":"383","key":"2704_CR20","doi-asserted-by":"publisher","first-page":"ra64","DOI":"10.1126\/scisignal.aaa4468","volume":"8","author":"CC Tu","year":"2015","unstructured":"Tu CC et al (2015) The kinase ABL phosphorylates the microprocessor subunit DGCR8 to stimulate primary microRNA processing in response to DNA damage. Sci Signal 8(383):ra64","journal-title":"Sci Signal"},{"issue":"1","key":"2704_CR21","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.cell.2009.06.044","volume":"139","author":"Z Paroo","year":"2009","unstructured":"Paroo Z et al (2009) Phosphorylation of the human microRNA-generating complex mediates MAPK\/Erk signaling. Cell 139(1):112\u2013122","journal-title":"Cell"},{"issue":"20","key":"2704_CR22","first-page":"9942","volume":"44","author":"MJ Warner","year":"2016","unstructured":"Warner MJ et al (2016) S6K2-mediated regulation of TRBP as a determinant of miRNA expression in human primary lymphatic endothelial cells. Nucleic Acids Res 44(20):9942\u20139955","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"2704_CR23","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.tem.2015.05.010","volume":"26","author":"D Qi","year":"2015","unstructured":"Qi D, Young LH (2015) AMPK: energy sensor and survival mechanism in the ischemic heart. Trends Endocrinol Metab 26(8):422\u2013429","journal-title":"Trends Endocrinol Metab"},{"key":"2704_CR24","doi-asserted-by":"crossref","unstructured":"Jurczak EM, Wong C, Li S, Braukmann F, Sawh AN, Duchaine TF, Miska EA, Roy R (2023) AMPK regulates small RNA pathway prevalence to mediate soma-to-germ line communication and establish germline stem cell quiescence. bioRxiv 11.15.567172","DOI":"10.1101\/2023.11.15.567172"},{"issue":"9","key":"2704_CR25","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1038\/s12276-023-01072-3","volume":"55","author":"H Sun","year":"2023","unstructured":"Sun H, Kemper JK (2023) MicroRNA regulation of AMPK in nonalcoholic fatty liver disease. Exp Mol Med 55(9):1974\u20131981","journal-title":"Exp Mol Med"},{"issue":"7640","key":"2704_CR26","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nature21025","volume":"542","author":"RJ Golden","year":"2017","unstructured":"Golden RJ et al (2017) An Argonaute phosphorylation cycle promotes microRNA-mediated silencing. Nature 542(7640):197\u2013202","journal-title":"Nature"},{"issue":"12","key":"2704_CR27","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1038\/s41594-023-01151-z","volume":"30","author":"L Sala","year":"2023","unstructured":"Sala L et al (2023) AGO2 silences mobile transposons in the nucleus of quiescent cells. Nat Struct Mol Biol 30(12):1985\u20131995","journal-title":"Nat Struct Mol Biol"},{"key":"2704_CR28","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaz2294","author":"D Santovito","year":"2020","unstructured":"Santovito D et al (2020) Noncanonical inhibition of caspase-3 by a nuclear microRNA confers endothelial protection by autophagy in atherosclerosis. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aaz2294","journal-title":"Sci Transl Med"},{"issue":"3","key":"2704_CR29","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1073\/pnas.1424217112","volume":"112","author":"G La Rocca","year":"2015","unstructured":"La Rocca G et al (2015) In vivo, Argonaute-bound microRNAs exist predominantly in a reservoir of low molecular weight complexes not associated with mRNA. Proc Natl Acad Sci U S A 112(3):767\u2013772","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"2704_CR30","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1080\/15548627.2018.1501135","volume":"14","author":"CC Liao","year":"2018","unstructured":"Liao CC et al (2018) Autophagic degradation of SQSTM1 inhibits ovarian cancer motility by decreasing DICER1 and AGO2 to induce MIRLET7A-3P. Autophagy 14(12):2065\u20132082","journal-title":"Autophagy"},{"issue":"2","key":"2704_CR31","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1172\/JCI89212","volume":"128","author":"HH Lai","year":"2018","unstructured":"Lai HH et al (2018) HIF-1alpha promotes autophagic proteolysis of Dicer and enhances tumor metastasis. J Clin Invest 128(2):625\u2013643","journal-title":"J Clin Invest"},{"issue":"6","key":"2704_CR32","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/embor.2013.53","volume":"14","author":"P Zhang","year":"2013","unstructured":"Zhang P, Zhang H (2013) Autophagy modulates miRNA-mediated gene silencing and selectively degrades AIN-1\/GW182 in C. elegans. EMBO Rep 14(6):568\u2013576","journal-title":"EMBO Rep"},{"issue":"12","key":"2704_CR33","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1038\/ncb2611","volume":"14","author":"D Gibbings","year":"2012","unstructured":"Gibbings D et al (2012) Selective autophagy degrades DICER and AGO2 and regulates miRNA activity. Nat Cell Biol 14(12):1314\u20131321","journal-title":"Nat Cell Biol"},{"key":"2704_CR34","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.yjmcc.2021.12.011","volume":"165","author":"R Lin","year":"2022","unstructured":"Lin R et al (2022) MiR-185-5p regulates the development of myocardial fibrosis. J Mol Cell Cardiol 165:130\u2013140","journal-title":"J Mol Cell Cardiol"},{"issue":"6","key":"2704_CR35","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1161\/CIRCRESAHA.113.300376","volume":"113","author":"T Doenst","year":"2013","unstructured":"Doenst T, Nguyen TD, Abel ED (2013) Cardiac metabolism in heart failure: implications beyond ATP production. Circ Res 113(6):709\u2013724","journal-title":"Circ Res"},{"issue":"1","key":"2704_CR36","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/s41392-023-01652-9","volume":"8","author":"Y Zhao","year":"2023","unstructured":"Zhao Y et al (2023) Hypoxia-induced signaling in the cardiovascular system: pathogenesis and therapeutic targets. Signal Transduct Target Ther 8(1):431","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"2704_CR37","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1155\/2009\/641082","volume":"27","author":"E Bostjancic","year":"2009","unstructured":"Bostjancic E, Zidar N, Glavac D (2009) MicroRNA microarray expression profiling in human myocardial infarction. Dis Markers 27(6):255\u2013268","journal-title":"Dis Markers"},{"issue":"9","key":"2704_CR38","first-page":"10140","volume":"10","author":"Y Wang","year":"2017","unstructured":"Wang Y et al (2017) MiR-139-5p protect against myocardial ischemia and reperfusion (I\/R) injury by targeting autophagy-related 4D and inhibiting AMPK\/mTOR\/ULK1 pathway. Int J Clin Exp Pathol 10(9):10140\u201310151","journal-title":"Int J Clin Exp Pathol"},{"issue":"10","key":"2704_CR39","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1016\/j.bbamcr.2011.06.006","volume":"1813","author":"M von Brandenstein","year":"2011","unstructured":"von Brandenstein M et al (2011) Protein kinase C alpha regulates nuclear pri-microRNA 15a release as part of endothelin signaling. Biochim Biophys Acta 1813(10):1793\u20131802","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"2704_CR40","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.molcel.2011.01.020","volume":"41","author":"X Zhang","year":"2011","unstructured":"Zhang X et al (2011) The ATM kinase induces microRNA biogenesis in the DNA damage response. Mol Cell 41(4):371\u2013383","journal-title":"Mol Cell"},{"issue":"266","key":"2704_CR41","doi-asserted-by":"publisher","first-page":"ra16","DOI":"10.1126\/scisignal.2003706","volume":"6","author":"S Hong","year":"2013","unstructured":"Hong S et al (2013) Signaling by p38 MAPK stimulates nuclear localization of the microprocessor component p68 for processing of selected primary microRNAs. Sci Signal 6(266):ra16","journal-title":"Sci Signal"},{"key":"2704_CR42","doi-asserted-by":"publisher","first-page":"110853","DOI":"10.1016\/j.biopha.2020.110853","volume":"132","author":"A Safa","year":"2020","unstructured":"Safa A et al (2020) MicroRNAs as regulators of ERK\/MAPK pathway: a comprehensive review. Biomed Pharmacother 132:110853","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"2704_CR43","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/sj.cr.7290105","volume":"12","author":"W Zhang","year":"2002","unstructured":"Zhang W, Liu HT (2002) MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res 12(1):9\u201318","journal-title":"Cell Res"},{"issue":"2","key":"2704_CR44","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.ajpath.2011.04.034","volume":"179","author":"E Shen","year":"2011","unstructured":"Shen E et al (2011) MicroRNAs involved in the mitogen-activated protein kinase cascades pathway during glucose-induced cardiomyocyte hypertrophy. Am J Pathol 179(2):639\u2013650","journal-title":"Am J Pathol"},{"issue":"5","key":"2704_CR45","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s00418-020-01847-z","volume":"153","author":"M Zhang","year":"2020","unstructured":"Zhang M et al (2020) MiR-145 alleviates Hcy-induced VSMC proliferation, migration, and phenotypic switch through repression of the PI3K\/Akt\/mTOR pathway. Histochem Cell Biol 153(5):357\u2013366","journal-title":"Histochem Cell Biol"},{"issue":"2","key":"2704_CR46","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3892\/mmr.2020.11164","volume":"22","author":"L Chen","year":"2020","unstructured":"Chen L, Bai J, Li Y (2020) miR-29 mediates exercise-induced skeletal muscle angiogenesis by targeting VEGFA, COL4A1 and COL4A2 via the PI3K\/Akt signaling pathway. Mol Med Rep 22(2):661\u2013670","journal-title":"Mol Med Rep"},{"issue":"2","key":"2704_CR47","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.devcel.2008.07.002","volume":"15","author":"S Wang","year":"2008","unstructured":"Wang S et al (2008) The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell 15(2):261\u2013271","journal-title":"Dev Cell"},{"key":"2704_CR48","doi-asserted-by":"publisher","first-page":"592362","DOI":"10.3389\/fcvm.2021.592362","volume":"8","author":"Z Lei","year":"2021","unstructured":"Lei Z et al (2021) MiR-132\/212 impairs cardiomyocytes contractility in the failing heart by suppressing SERCA2a. Front Cardiovasc Med 8:592362","journal-title":"Front Cardiovasc Med"},{"key":"2704_CR49","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/ncomms2090","volume":"3","author":"A Ucar","year":"2012","unstructured":"Ucar A et al (2012) The miRNA-212\/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy. Nat Commun 3:1078","journal-title":"Nat Commun"},{"issue":"8","key":"2704_CR50","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s00109-019-01796-8","volume":"97","author":"AL Simao","year":"2019","unstructured":"Simao AL et al (2019) Skeletal muscle miR-34a\/SIRT1:AMPK axis is activated in experimental and human non-alcoholic steatohepatitis. J Mol Med (Berl) 97(8):1113\u20131126","journal-title":"J Mol Med (Berl)"},{"key":"2704_CR51","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.omtn.2021.10.013","volume":"26","author":"N Zeng","year":"2021","unstructured":"Zeng N et al (2021) Diverging targets mediate the pathological roleof miR-199a-5p and miR-199a-3p by promoting cardiac hypertrophy and fibrosis. Mol Ther Nucleic Acids 26:1035\u20131050","journal-title":"Mol Ther Nucleic Acids"},{"issue":"7","key":"2704_CR52","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/cdd.2015.95","volume":"24","author":"Z Li","year":"2017","unstructured":"Li Z et al (2017) MiR-199a impairs autophagy and induces cardiac hypertrophy through mTOR activation. Cell Death Differ 24(7):1205\u20131213","journal-title":"Cell Death Differ"},{"issue":"4","key":"2704_CR53","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cmet.2009.08.015","volume":"10","author":"SY Chan","year":"2009","unstructured":"Chan SY et al (2009) MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1\/2. Cell Metab 10(4):273\u2013284","journal-title":"Cell Metab"},{"issue":"23","key":"2704_CR54","doi-asserted-by":"publisher","first-page":"15878","DOI":"10.1074\/jbc.M800731200","volume":"283","author":"P Fasanaro","year":"2008","unstructured":"Fasanaro P et al (2008) MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J Biol Chem 283(23):15878\u201315883","journal-title":"J Biol Chem"},{"issue":"2","key":"2704_CR55","doi-asserted-by":"publisher","first-page":"e000121","DOI":"10.1161\/JAHA.113.000121","volume":"2","author":"A Qiao","year":"2013","unstructured":"Qiao A et al (2013) MicroRNA-210 decreases heme levels by targeting ferrochelatase in cardiomyocytes. J Am Heart Assoc 2(2):e000121","journal-title":"J Am Heart Assoc"},{"issue":"30","key":"2704_CR56","doi-asserted-by":"publisher","first-page":"4362","DOI":"10.1038\/onc.2010.193","volume":"29","author":"Z Chen","year":"2010","unstructured":"Chen Z et al (2010) Hypoxia-regulated microRNA-210 modulates mitochondrial function and decreases ISCU and COX10 expression. Oncogene 29(30):4362\u20134368","journal-title":"Oncogene"},{"issue":"7224","key":"2704_CR57","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1038\/nature07511","volume":"456","author":"T Thum","year":"2008","unstructured":"Thum T et al (2008) MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456(7224):980\u2013984","journal-title":"Nature"},{"issue":"6","key":"2704_CR58","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1161\/CIRCULATIONAHA.111.039008","volume":"124","author":"J Fiedler","year":"2011","unstructured":"Fiedler J et al (2011) MicroRNA-24 regulates vascularity after myocardial infarction. Circulation 124(6):720\u2013730","journal-title":"Circulation"},{"issue":"7","key":"2704_CR59","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1161\/CIRCRESAHA.108.193102","volume":"104","author":"S Rane","year":"2009","unstructured":"Rane S et al (2009) Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes. Circ Res 104(7):879\u2013886","journal-title":"Circ Res"},{"issue":"7256","key":"2704_CR60","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/nature08195","volume":"460","author":"KR Cordes","year":"2009","unstructured":"Cordes KR et al (2009) MiR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 460(7256):705\u2013710","journal-title":"Nature"},{"issue":"2","key":"2704_CR61","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.devcel.2008.07.008","volume":"15","author":"JE Fish","year":"2008","unstructured":"Fish JE et al (2008) MiR-126 regulates angiogenic signaling and vascular integrity. Dev Cell 15(2):272\u2013284","journal-title":"Dev Cell"},{"issue":"5985","key":"2704_CR62","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1126\/science.1189862","volume":"328","author":"KJ Rayner","year":"2010","unstructured":"Rayner KJ et al (2010) MiR-33 contributes to the regulation of cholesterol homeostasis. Science 328(5985):1570\u20131573","journal-title":"Science"},{"issue":"5985","key":"2704_CR63","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1126\/science.1189123","volume":"328","author":"SH Najafi-Shoushtari","year":"2010","unstructured":"Najafi-Shoushtari SH et al (2010) MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science 328(5985):1566\u20131569","journal-title":"Science"},{"issue":"1","key":"2704_CR64","doi-asserted-by":"publisher","first-page":"13","DOI":"10.5551\/jat.RV22045","volume":"33","author":"T Horie","year":"2026","unstructured":"Horie T et al (2026) Critical role of microRNA-33a\/b in cardiovascular and metabolic disease: molecular mechanisms and therapeutic perspectives. J Atheroscler Thromb 33(1):13\u201319","journal-title":"J Atheroscler Thromb"},{"issue":"22","key":"2704_CR65","doi-asserted-by":"publisher","first-page":"9232","DOI":"10.1073\/pnas.1102281108","volume":"108","author":"A Davalos","year":"2011","unstructured":"Davalos A et al (2011) MiR-33a\/b contribute to the regulation of fatty acid metabolism and insulin signaling. Proc Natl Acad Sci U S A 108(22):9232\u20139237","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"2704_CR66","doi-asserted-by":"publisher","first-page":"325","DOI":"10.21037\/cdt-21-743","volume":"12","author":"HT Yang","year":"2022","unstructured":"Yang HT et al (2022) MicroRNA-155 inhibition attenuates myocardial infarction-induced connexin 43 degradation in cardiomyocytes by reducing pro-inflammatory macrophage activation. Cardiovasc Diagn Ther 12(3):325\u2013339","journal-title":"Cardiovasc Diagn Ther"},{"key":"2704_CR67","doi-asserted-by":"publisher","first-page":"625","DOI":"10.3389\/fimmu.2020.00625","volume":"11","author":"S Pasca","year":"2020","unstructured":"Pasca S et al (2020) MicroRNA-155 implication in M1 polarization and the impact in inflammatory diseases. Front Immunol 11:625","journal-title":"Front Immunol"},{"key":"2704_CR68","doi-asserted-by":"publisher","DOI":"10.3390\/ncrna3030022","author":"U Testa","year":"2017","unstructured":"Testa U et al (2017) MiR-146 and miR-155: two key modulators of immune response and tumor development. Noncoding RNA. https:\/\/doi.org\/10.3390\/ncrna3030022","journal-title":"Noncoding RNA"},{"issue":"5","key":"2704_CR69","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/cmi.2011.26","volume":"8","author":"MA Nahid","year":"2011","unstructured":"Nahid MA, Satoh M, Chan EK (2011) MicroRNA in TLR signaling and endotoxin tolerance. Cell Mol Immunol 8(5):388\u2013403","journal-title":"Cell Mol Immunol"},{"issue":"5","key":"2704_CR70","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1073\/pnas.0610731104","volume":"104","author":"RM O'Connell","year":"2007","unstructured":"O\u2019Connell RM et al (2007) MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci U S A 104(5):1604\u20131609","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2704_CR71","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1161\/HYPERTENSIONAHA.112.197301","volume":"60","author":"HX Sun","year":"2012","unstructured":"Sun HX et al (2012) Essential role of microRNA-155 in regulating endothelium-dependent vasorelaxation by targeting endothelial nitric oxide synthase. Hypertension 60(6):1407\u20131414","journal-title":"Hypertension"},{"issue":"11","key":"2704_CR72","doi-asserted-by":"publisher","first-page":"4190","DOI":"10.1172\/JCI61716","volume":"122","author":"M Nazari-Jahantigh","year":"2012","unstructured":"Nazari-Jahantigh M et al (2012) MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages. J Clin Invest 122(11):4190\u20134202","journal-title":"J Clin Invest"},{"issue":"7","key":"2704_CR73","doi-asserted-by":"publisher","first-page":"e0159724","DOI":"10.1371\/journal.pone.0159724","volume":"11","author":"KA Jablonski","year":"2016","unstructured":"Jablonski KA et al (2016) Control of the inflammatory macrophage transcriptional signature by miR-155. PLoS One 11(7):e0159724","journal-title":"PLoS One"},{"issue":"1","key":"2704_CR74","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1600-065X.2011.01091.x","volume":"246","author":"ST Smale","year":"2012","unstructured":"Smale ST (2012) Dimer-specific regulatory mechanisms within the NF-kappaB family of transcription factors. Immunol Rev 246(1):193\u2013204","journal-title":"Immunol Rev"},{"issue":"33","key":"2704_CR75","doi-asserted-by":"publisher","first-page":"12481","DOI":"10.1073\/pnas.0605298103","volume":"103","author":"KD Taganov","year":"2006","unstructured":"Taganov KD et al (2006) NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A 103(33):12481\u201312486","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2704_CR76","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/s41467-017-00972-z","volume":"8","author":"M Mann","year":"2017","unstructured":"Mann M et al (2017) An NF-kappaB-microRNA regulatory network tunes macrophage inflammatory responses. Nat Commun 8(1):851","journal-title":"Nat Commun"},{"issue":"3","key":"2704_CR77","first-page":"2995","volume":"18","author":"AJ Ma","year":"2018","unstructured":"Ma AJ et al (2018) Associations of CXCL16, miR-146a and miR-146b in atherosclerotic apolipoprotein E-knockout mice. Mol Med Rep 18(3):2995\u20133002","journal-title":"Mol Med Rep"},{"issue":"19","key":"2704_CR78","doi-asserted-by":"publisher","first-page":"e70121","DOI":"10.1111\/jcmm.70121","volume":"28","author":"AP Ardinal","year":"2024","unstructured":"Ardinal AP, Wiyono AV, Estiko RI (2024) Unveiling the therapeutic potential of miR-146a: targeting innate inflammation in atherosclerosis. J Cell Mol Med 28(19):e70121","journal-title":"J Cell Mol Med"},{"key":"2704_CR79","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3389\/fcimb.2012.00073","volume":"2","author":"TJ Cremer","year":"2012","unstructured":"Cremer TJ et al (2012) MiR-155 induction by microbes\/microbial ligands requires NF-kappaB-dependent de novo protein synthesis. Front Cell Infect Microbiol 2:73","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"2704_CR80","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/cvr\/cvp015","volume":"82","author":"S Roy","year":"2009","unstructured":"Roy S et al (2009) MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. Cardiovasc Res 82(1):21\u201329","journal-title":"Cardiovasc Res"},{"issue":"5","key":"2704_CR81","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/s41419-019-1599-9","volume":"10","author":"Y Su","year":"2019","unstructured":"Su Y et al (2019) MicroRNA-181a-5p and microRNA-181a-3p cooperatively restrict vascular inflammation and atherosclerosis. Cell Death Dis 10(5):365","journal-title":"Cell Death Dis"},{"key":"2704_CR82","doi-asserted-by":"publisher","first-page":"986423","DOI":"10.3389\/fcvm.2022.986423","volume":"9","author":"L Wu","year":"2022","unstructured":"Wu L, Li Z, Li Y (2022) The crosstalk between STAT3 and microRNA in cardiac diseases and protection. Front Cardiovasc Med 9:986423","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"2704_CR83","first-page":"143","volume":"1","author":"A Haghikia","year":"2012","unstructured":"Haghikia A et al (2012) STAT3 regulation of and by microRNAs in development and disease. JAKSTAT 1(3):143\u2013150","journal-title":"JAKSTAT"},{"issue":"1","key":"2704_CR84","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1586\/erm.10.103","volume":"11","author":"MS Jamaluddin","year":"2011","unstructured":"Jamaluddin MS et al (2011) MiRNAs: roles and clinical applications in vascular disease. Expert Rev Mol Diagn 11(1):79\u201389","journal-title":"Expert Rev Mol Diagn"},{"key":"2704_CR85","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.molimm.2025.08.018","volume":"186","author":"Q Yang","year":"2025","unstructured":"Yang Q, Ji H, Modarresi Chahardehi A (2025) JAK\/STAT pathway in myocardial infarction: crossroads of immune signaling and cardiac remodeling. Mol Immunol 186:206\u2013217","journal-title":"Mol Immunol"},{"issue":"12","key":"2704_CR86","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1093\/cvr\/cvab007","volume":"117","author":"LB Roberts","year":"2021","unstructured":"Roberts LB et al (2021) An update on the roles of immune system-derived microRNAs in cardiovascular diseases. Cardiovasc Res 117(12):2434\u20132449","journal-title":"Cardiovasc Res"},{"key":"2704_CR87","doi-asserted-by":"publisher","first-page":"103030","DOI":"10.1016\/j.arr.2026.103030","volume":"115","author":"D Zhong","year":"2026","unstructured":"Zhong D et al (2026) Exercise and the hallmarks of cardiovascular aging. Ageing Res Rev 115:103030","journal-title":"Ageing Res Rev"},{"issue":"6","key":"2704_CR88","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.4161\/cc.9.6.11006","volume":"9","author":"SY Chan","year":"2010","unstructured":"Chan SY, Loscalzo J (2010) MicroRNA-210: a unique and pleiotropic hypoxamir. Cell Cycle 9(6):1072\u20131083","journal-title":"Cell Cycle"},{"key":"2704_CR89","doi-asserted-by":"publisher","first-page":"3123968","DOI":"10.1155\/2020\/3123968","volume":"2020","author":"C Hu","year":"2020","unstructured":"Hu C et al (2020) P38\/JNK is required for the proliferation and phenotype changes of vascular smooth muscle cells induced by L3MBTL4 in essential hypertension. Int J Hypertens 2020:3123968","journal-title":"Int J Hypertens"},{"key":"2704_CR90","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/bs.apha.2016.08.003","volume":"78","author":"FZ Saddouk","year":"2017","unstructured":"Saddouk FZ, Ginnan R, Singer HA (2017) Ca(2+)\/calmodulin-dependent protein kinase II in vascular smooth muscle. Adv Pharmacol 78:171\u2013202","journal-title":"Adv Pharmacol"},{"issue":"5","key":"2704_CR91","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1073\/pnas.0707493105","volume":"105","author":"TA Harris","year":"2008","unstructured":"Harris TA et al (2008) MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc Natl Acad Sci U S A 105(5):1516\u20131521","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"2704_CR92","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s11906-016-0696-8","volume":"18","author":"M Nemecz","year":"2016","unstructured":"Nemecz M et al (2016) Role of microRNA in endothelial dysfunction and hypertension. Curr Hypertens Rep 18(12):87","journal-title":"Curr Hypertens Rep"},{"issue":"12","key":"2704_CR93","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1038\/cdd.2009.153","volume":"16","author":"L Elia","year":"2009","unstructured":"Elia L et al (2009) The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease. Cell Death Differ 16(12):1590\u20131598","journal-title":"Cell Death Differ"},{"issue":"7","key":"2704_CR94","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/emmm.201202318","volume":"5","author":"HS Cheng","year":"2013","unstructured":"Cheng HS et al (2013) MicroRNA-146 represses endothelial activation by inhibiting pro-inflammatory pathways. EMBO Mol Med 5(7):1017\u20131034","journal-title":"EMBO Mol Med"},{"issue":"3","key":"2704_CR95","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.tcm.2013.09.002","volume":"24","author":"X Sun","year":"2014","unstructured":"Sun X, Sit A, Feinberg MW (2014) Role of miR-181 family in regulating vascular inflammation and immunity. Trends Cardiovasc Med 24(3):105\u2013112","journal-title":"Trends Cardiovasc Med"},{"issue":"35","key":"2704_CR96","doi-asserted-by":"publisher","first-page":"13027","DOI":"10.1073\/pnas.0805038105","volume":"105","author":"E van Rooij","year":"2008","unstructured":"van Rooij E et al (2008) Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci U S A 105(35):13027\u201313032","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"44","key":"2704_CR97","doi-asserted-by":"publisher","first-page":"33652","DOI":"10.1074\/jbc.M110.152090","volume":"285","author":"I Gerin","year":"2010","unstructured":"Gerin I et al (2010) Expression of miR-33 from an SREBP2 intron inhibits cholesterol export and fatty acid oxidation. J Biol Chem 285(44):33652\u201333661","journal-title":"J Biol Chem"},{"issue":"4","key":"2704_CR98","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/s12276-021-00611-0","volume":"53","author":"Y Kim","year":"2021","unstructured":"Kim Y et al (2021) The interplay of microRNAs and transcription factors in autophagy regulation in nonalcoholic fatty liver disease. Exp Mol Med 53(4):548\u2013559","journal-title":"Exp Mol Med"},{"issue":"5","key":"2704_CR99","doi-asserted-by":"publisher","first-page":"6608","DOI":"10.3892\/mmr.2017.7447","volume":"16","author":"Y Liu","year":"2017","unstructured":"Liu Y et al (2017) Differential miRNA expression profiles in human keratinocytes in response to protein kinase C inhibitor. Mol Med Rep 16(5):6608\u20136619","journal-title":"Mol Med Rep"},{"issue":"29","key":"2704_CR100","doi-asserted-by":"publisher","first-page":"25586","DOI":"10.1074\/jbc.M110.208066","volume":"286","author":"N Dey","year":"2011","unstructured":"Dey N et al (2011) MicroRNA-21 orchestrates high glucose-induced signals to TOR complex 1, resulting in renal cell pathology in diabetes. J Biol Chem 286(29):25586\u201325603","journal-title":"J Biol Chem"},{"issue":"11","key":"2704_CR101","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1038\/nm.2052","volume":"15","author":"P Geraldes","year":"2009","unstructured":"Geraldes P et al (2009) Activation of PKC-delta and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy. Nat Med 15(11):1298\u20131306","journal-title":"Nat Med"},{"issue":"3","key":"2704_CR102","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1097\/MOL.0000000000000603","volume":"30","author":"LR Sedgeman","year":"2019","unstructured":"Sedgeman LR, Michell DL, Vickers KC (2019) Integrative roles of microRNAs in lipid metabolism and dyslipidemia. Curr Opin Lipidol 30(3):165\u2013171","journal-title":"Curr Opin Lipidol"},{"issue":"13","key":"2704_CR103","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1016\/j.febslet.2014.05.011","volume":"588","author":"WM Yang","year":"2014","unstructured":"Yang WM et al (2014) Induction of miR-29a by saturated fatty acids impairs insulin signaling and glucose uptake through translational repression of IRS-1 in myocytes. FEBS Lett 588(13):2170\u20132176","journal-title":"FEBS Lett"},{"issue":"4","key":"2704_CR104","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.molcel.2014.12.034","volume":"57","author":"P Ye","year":"2015","unstructured":"Ye P et al (2015) An mTORC1-Mdm2-Drosha axis for miRNA biogenesis in response to glucose- and amino acid-deprivation. Mol Cell 57(4):708\u2013720","journal-title":"Mol Cell"},{"issue":"3","key":"2704_CR105","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1161\/CIRCRESAHA.111.247452","volume":"110","author":"EE Creemers","year":"2012","unstructured":"Creemers EE, Tijsen AJ, Pinto YM (2012) Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? Circ Res 110(3):483\u2013495","journal-title":"Circ Res"},{"issue":"3","key":"2704_CR106","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrd.2016.246","volume":"16","author":"R Rupaimoole","year":"2017","unstructured":"Rupaimoole R, Slack FJ (2017) MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov 16(3):203\u2013222","journal-title":"Nat Rev Drug Discov"},{"issue":"15","key":"2704_CR107","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1001\/jama.2016.3609","volume":"315","author":"ML O'Donoghue","year":"2016","unstructured":"O\u2019Donoghue ML et al (2016) Effect of Losmapimod on cardiovascular outcomes in patients hospitalized with acute myocardial infarction: a randomized clinical trial. JAMA 315(15):1591\u20131599","journal-title":"JAMA"},{"issue":"1","key":"2704_CR108","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1161\/CIRCRESAHA.116.303613","volume":"116","author":"H Lal","year":"2015","unstructured":"Lal H et al (2015) The GSK-3 family as therapeutic target for myocardial diseases. Circ Res 116(1):138\u2013149","journal-title":"Circ Res"},{"issue":"2","key":"2704_CR109","doi-asserted-by":"publisher","first-page":"118616","DOI":"10.1016\/j.bbamcr.2019.118616","volume":"1867","author":"F Ahmad","year":"2020","unstructured":"Ahmad F, Woodgett JR (2020) Emerging roles of GSK-3\u03b1 in pathophysiology: emphasis on cardio-metabolic disorders. Biochim Biophys Acta Mol Cell Res 1867(2):118616","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"7","key":"2704_CR110","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1161\/CIRCRESAHA.122.321431","volume":"131","author":"P Umbarkar","year":"2022","unstructured":"Umbarkar P et al (2022) Fibroblast GSK-3alpha promotes fibrosis via RAF-MEK-ERK pathway in the injured heart. Circ Res 131(7):620\u2013636","journal-title":"Circ Res"},{"issue":"7","key":"2704_CR111","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.jacc.2014.04.068","volume":"64","author":"F Ahmad","year":"2014","unstructured":"Ahmad F et al (2014) Cardiomyocyte-specific deletion of Gsk3alpha mitigates post-myocardial infarction remodeling, contractile dysfunction, and heart failure. J Am Coll Cardiol 64(7):696\u2013706","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"2704_CR112","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1161\/CIRCULATIONAHA.109.889048","volume":"121","author":"EM Small","year":"2010","unstructured":"Small EM, Frost RJ, Olson EN (2010) MicroRNAs add a new dimension to cardiovascular disease. Circulation 121(8):1022\u20131032","journal-title":"Circulation"},{"key":"2704_CR113","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-026-04408-4","author":"J Bauersachs","year":"2026","unstructured":"Bauersachs J et al (2026) The microRNA inhibitor CDR132L in patients with reduced left ventricular ejection fraction after myocardial infarction: a randomized phase 2 trial. Nat Med. https:\/\/doi.org\/10.1038\/s41591-026-04408-4","journal-title":"Nat Med"},{"issue":"3","key":"2704_CR114","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/ejhf.3139","volume":"26","author":"J Bauersachs","year":"2024","unstructured":"Bauersachs J et al (2024) Efficacy and safety of CDR132L in patients with reduced left ventricular ejection fraction after myocardial infarction: rationale and design of the HF-REVERT trial. Eur J Heart Fail 26(3):674\u2013682","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"2704_CR115","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/eurheartj\/ehaa898","volume":"42","author":"J Taubel","year":"2021","unstructured":"Taubel J et al (2021) Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study. Eur Heart J 42(2):178\u2013188","journal-title":"Eur Heart J"},{"issue":"7","key":"2704_CR116","doi-asserted-by":"publisher","first-page":"851","DOI":"10.15252\/emmm.201100899","volume":"6","author":"E van Rooij","year":"2014","unstructured":"van Rooij E, Kauppinen S (2014) Development of microRNA therapeutics is coming of age. EMBO Mol Med 6(7):851\u2013864","journal-title":"EMBO Mol Med"},{"issue":"1","key":"2704_CR117","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jjcc.2025.06.004","volume":"87","author":"R Patel","year":"2026","unstructured":"Patel R et al (2026) Nanoparticle-driven drug delivery system for cardiovascular treatment. J Cardiol 87(1):23\u201337","journal-title":"J Cardiol"},{"issue":"3","key":"2704_CR118","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1097\/HCO.0000000000000850","volume":"36","author":"C Boada","year":"2021","unstructured":"Boada C et al (2021) RNA therapeutics for cardiovascular disease. Curr Opin Cardiol 36(3):256\u2013263","journal-title":"Curr Opin Cardiol"},{"key":"2704_CR119","doi-asserted-by":"publisher","first-page":"999404","DOI":"10.3389\/fphar.2022.999404","volume":"13","author":"F Yang","year":"2022","unstructured":"Yang F et al (2022) Nanoparticle-based drug delivery systems for the treatment of cardiovascular diseases. Front Pharmacol 13:999404","journal-title":"Front Pharmacol"},{"issue":"5","key":"2704_CR120","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1161\/CIRCULATIONAHA.113.008364","volume":"130","author":"H Lal","year":"2014","unstructured":"Lal H et al (2014) Cardiac fibroblast glycogen synthase kinase-3beta regulates ventricular remodeling and dysfunction in ischemic heart. Circulation 130(5):419\u2013430","journal-title":"Circulation"},{"issue":"12","key":"2704_CR121","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1038\/nbt.3701","volume":"34","author":"OR Faridani","year":"2016","unstructured":"Faridani OR et al (2016) Single-cell sequencing of the small-RNA transcriptome. Nat Biotechnol 34(12):1264\u20131266","journal-title":"Nat Biotechnol"},{"issue":"1","key":"2704_CR122","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s42003-020-01636-3","volume":"4","author":"B Molenaar","year":"2021","unstructured":"Molenaar B et al (2021) Single-cell transcriptomics following ischemic injury identifies a role for B2M in cardiac repair. Commun Biol 4(1):146","journal-title":"Commun Biol"},{"issue":"6","key":"2704_CR123","doi-asserted-by":"publisher","first-page":"110809","DOI":"10.1016\/j.celrep.2022.110809","volume":"39","author":"M Wehrens","year":"2022","unstructured":"Wehrens M et al (2022) Single-cell transcriptomics provides insights into hypertrophic cardiomyopathy. Cell Rep 39(6):110809","journal-title":"Cell Rep"},{"issue":"21","key":"2704_CR124","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1161\/CIRCULATIONAHA.120.048378","volume":"142","author":"H Pan","year":"2020","unstructured":"Pan H et al (2020) Single-cell genomics reveals a novel cell state during smooth muscle cell phenotypic switching and potential therapeutic targets for atherosclerosis in mouse and human. Circulation 142(21):2060\u20132075","journal-title":"Circulation"},{"issue":"12","key":"2704_CR125","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.tig.2025.06.005","volume":"41","author":"A Robles-Remacho","year":"2025","unstructured":"Robles-Remacho A et al (2025) Spatially resolved microRNA expression in tissues: technologies, challenges, and opportunities. Trends Genet 41(12):1131\u20131143","journal-title":"Trends Genet"},{"issue":"23","key":"2704_CR126","doi-asserted-by":"publisher","first-page":"6760","DOI":"10.1016\/j.cell.2024.09.001","volume":"187","author":"Z Bai","year":"2024","unstructured":"Bai Z et al (2024) Spatially exploring RNA biology in archival formalin-fixed paraffin-embedded tissues. Cell 187(23):6760-6779 e24","journal-title":"Cell"},{"issue":"6","key":"2704_CR127","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/nmeth.3810","volume":"13","author":"EL Van Nostrand","year":"2016","unstructured":"Van Nostrand EL et al (2016) Robust transcriptome-wide discovery of RNA-binding protein binding sites with enhanced CLIP (eCLIP). Nat Methods 13(6):508\u2013514","journal-title":"Nat Methods"},{"key":"2704_CR128","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.88732","author":"JH Qu","year":"2024","unstructured":"Qu JH et al (2024) Reprogramming of cardiac phosphoproteome, proteome, and transcriptome confers resilience to chronic adenylyl cyclase-driven stress. Elife. https:\/\/doi.org\/10.7554\/eLife.88732","journal-title":"Elife"},{"issue":"4","key":"2704_CR129","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.celrep.2013.10.017","volume":"5","author":"KM Herbert","year":"2013","unstructured":"Herbert KM et al (2013) Phosphorylation of DGCR8 increases its intracellular stability and induces a progrowth miRNA profile. Cell Rep 5(4):1070\u20131081","journal-title":"Cell Rep"},{"key":"2704_CR130","doi-asserted-by":"publisher","first-page":"13694","DOI":"10.1038\/ncomms13694","volume":"7","author":"M Fareh","year":"2016","unstructured":"Fareh M et al (2016) TRBP ensures efficient Dicer processing of precursor microRNA in RNA-crowded environments. Nat Commun 7:13694","journal-title":"Nat Commun"},{"issue":"6","key":"2704_CR131","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.cell.2014.05.010","volume":"157","author":"PD Hsu","year":"2014","unstructured":"Hsu PD, Lander ES, Zhang F (2014) Development and applications of CRISPR-Cas9 for genome engineering. Cell 157(6):1262\u20131278","journal-title":"Cell"},{"issue":"2","key":"2704_CR132","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1021\/acschembio.7b00657","volume":"13","author":"M Kampmann","year":"2018","unstructured":"Kampmann M (2018) CRISPRi and CRISPRa screens in mammalian cells for precision biology and medicine. ACS Chem Biol 13(2):406\u2013416","journal-title":"ACS Chem Biol"},{"key":"2704_CR133","doi-asserted-by":"publisher","DOI":"10.1126\/science.aah7111","author":"SJ Liu","year":"2017","unstructured":"Liu SJ et al (2017) CRISPRi-based genome-scale identification of functional long noncoding RNA loci in human cells. Science. https:\/\/doi.org\/10.1126\/science.aah7111","journal-title":"Science"},{"issue":"7818","key":"2704_CR134","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/s41586-020-2077-3","volume":"583","author":"EL Van Nostrand","year":"2020","unstructured":"Van Nostrand EL et al (2020) A large-scale binding and functional map of human RNA-binding proteins. Nature 583(7818):711\u2013719","journal-title":"Nature"},{"issue":"3","key":"2704_CR135","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1172\/JCI84424","volume":"127","author":"BD Adams","year":"2017","unstructured":"Adams BD et al (2017) Targeting noncoding RNAs in disease. J Clin Invest 127(3):761\u2013771","journal-title":"J Clin Invest"},{"issue":"7","key":"2704_CR136","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1161\/CIRCULATIONAHA.112.125013","volume":"126","author":"T Thum","year":"2012","unstructured":"Thum T, Lorenzen JM (2012) Cardiac fibrosis revisited by microRNA therapeutics. Circulation 126(7):800\u2013802","journal-title":"Circulation"},{"issue":"6","key":"2704_CR137","first-page":"5335","volume":"19","author":"DW Liu","year":"2019","unstructured":"Liu DW et al (2019) Downregulation of microRNA-199a-5p attenuates hypoxia\/reoxygenation-induced cytotoxicity in cardiomyocytes by targeting the HIF-1\u03b1-GSK3\u03b2-mPTP axis. Mol Med Rep 19(6):5335\u20135344","journal-title":"Mol Med Rep"},{"issue":"5","key":"2704_CR138","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.cmet.2013.04.004","volume":"17","author":"GW Dorn 2nd","year":"2013","unstructured":"Dorn GW 2nd (2013) MiR-34a and the cardiomyopathy of senescence: SALT PNUTS, SALT PNUTS! Cell Metab 17(5):629\u2013630","journal-title":"Cell Metab"},{"issue":"7","key":"2704_CR139","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1038\/s41418-017-0047-6","volume":"25","author":"I Fomison-Nurse","year":"2018","unstructured":"Fomison-Nurse I et al (2018) Diabetes induces the activation of pro-ageing miR-34a in the heart, but has differential effects on cardiomyocytes and cardiac progenitor cells. Cell Death Differ 25(7):1336\u20131349","journal-title":"Cell Death Differ"},{"issue":"3","key":"2704_CR140","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s13105-021-00814-z","volume":"77","author":"C Li","year":"2021","unstructured":"Li C et al (2021) Role of the microRNA-29 family in myocardial fibrosis. J Physiol Biochem 77(3):365\u2013376","journal-title":"J Physiol Biochem"},{"key":"2704_CR141","doi-asserted-by":"publisher","first-page":"903","DOI":"10.3389\/fphar.2018.00903","volume":"9","author":"N Li","year":"2018","unstructured":"Li N, Zhou H, Tang Q (2018) MiR-133: a suppressor of cardiac remodeling? Front Pharmacol 9:903","journal-title":"Front Pharmacol"},{"issue":"1\u20132","key":"2704_CR142","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s11010-017-3140-8","volume":"439","author":"SY Lee","year":"2018","unstructured":"Lee SY et al (2018) MicroRNA-133a attenuates cardiomyocyte hypertrophy by targeting PKCdelta and Gq. Mol Cell Biochem 439(1\u20132):105\u2013115","journal-title":"Mol Cell Biochem"},{"issue":"4","key":"2704_CR143","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nm1569","volume":"13","author":"B Yang","year":"2007","unstructured":"Yang B et al (2007) The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med 13(4):486\u2013491","journal-title":"Nat Med"},{"issue":"17","key":"2704_CR144","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1111\/jcmm.17835","volume":"27","author":"T Wang","year":"2023","unstructured":"Wang T et al (2023) MALAT1\/miR-185-5p mediated high glucose-induced oxidative stress, mitochondrial injury and cardiomyocyte apoptosis via the RhoA\/ROCK pathway. J Cell Mol Med 27(17):2495\u20132506","journal-title":"J Cell Mol Med"},{"issue":"5935","key":"2704_CR145","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1126\/science.1174381","volume":"324","author":"A Bonauer","year":"2009","unstructured":"Bonauer A et al (2009) MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 324(5935):1710\u20131713","journal-title":"Science"},{"issue":"4","key":"2704_CR146","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1093\/cvr\/cvu162","volume":"103","author":"JM Daniel","year":"2014","unstructured":"Daniel JM et al (2014) Inhibition of miR-92a improves re-endothelialization and prevents neointima formation following vascular injury. Cardiovasc Res 103(4):564\u2013572","journal-title":"Cardiovasc Res"},{"issue":"9","key":"2704_CR147","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1172\/JCI38864","volume":"119","author":"T Boettger","year":"2009","unstructured":"Boettger T et al (2009) Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143\/145 gene cluster. J Clin Invest 119(9):2634\u20132647","journal-title":"J Clin Invest"},{"issue":"18","key":"2704_CR148","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1101\/gad.1842409","volume":"23","author":"M Xin","year":"2009","unstructured":"Xin M et al (2009) MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury. Genes Dev 23(18):2166\u20132178","journal-title":"Genes Dev"},{"issue":"9","key":"2704_CR149","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.1172\/JCI36154","volume":"119","author":"TE Callis","year":"2009","unstructured":"Callis TE et al (2009) MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J Clin Invest 119(9):2772\u20132786","journal-title":"J Clin Invest"},{"issue":"11","key":"2704_CR150","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1172\/JCI43604","volume":"120","author":"DM Patrick","year":"2010","unstructured":"Patrick DM et al (2010) Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice. J Clin Invest 120(11):3912\u20133916","journal-title":"J Clin Invest"},{"issue":"5","key":"2704_CR151","doi-asserted-by":"publisher","first-page":"455","DOI":"10.7150\/ijbs.4630","volume":"9","author":"Y Zhang","year":"2013","unstructured":"Zhang Y et al (2013) Overexpression of microRNA-1 causes atrioventricular block in rodents. Int J Biol Sci 9(5):455\u2013462","journal-title":"Int J Biol Sci"},{"issue":"4","key":"2704_CR152","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1161\/CIRCRESAHA.108.181651","volume":"104","author":"D Terentyev","year":"2009","unstructured":"Terentyev D et al (2009) MiR-1 overexpression enhances Ca(2+) release and promotes cardiac arrhythmogenesis by targeting PP2A regulatory subunit B56alpha and causing CaMKII-dependent hyperphosphorylation of RyR2. Circ Res 104(4):514\u2013521","journal-title":"Circ Res"},{"issue":"1","key":"2704_CR153","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/s41598-018-19360-8","volume":"8","author":"E Chukwurah","year":"2018","unstructured":"Chukwurah E, Patel RC (2018) Stress-induced TRBP phosphorylation enhances its interaction with PKR to regulate cellular survival. Sci Rep 8(1):1020","journal-title":"Sci Rep"},{"key":"2704_CR154","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev.physiol.70.113006.100526","volume":"70","author":"MC Simon","year":"2008","unstructured":"Simon MC et al (2008) Hypoxia-induced signaling in the cardiovascular system. Annu Rev Physiol 70:51\u201371","journal-title":"Annu Rev Physiol"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-026-02704-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-026-02704-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-026-02704-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T07:01:51Z","timestamp":1784703711000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-026-02704-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":154,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["2704"],"URL":"https:\/\/doi.org\/10.1007\/s00109-026-02704-7","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"assertion":[{"value":"7 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"N\/A.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N\/A.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AI was carefully used to polish the manuscript language.","order":3,"name":"Ethics","label":"Declaration of generative AI use","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","label":"Conflict of interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"98"}}